Clarksville, MD, United States of America

Jun O Liu

This inventor holds 35 USPTO granted patents and 14 published patent applications, plus 2 CIPO patents and 6 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Johns Hopkins University, Massachusetts Institute of Technology, Texas A&M University System. Active years: 1999-2026.

USPTO Granted Patents = 35 (Patent Applications = 14)

% Patents Active = 88.6

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 6 (Patent Applications = 6)

Average Co-Inventor Count = 4.4

ph-index = 6

Forward Citations = 226(Granted Patents)

Location History:

Cambridge, MA (US) (1999 - 2004)
Clarkesville, MD (US) (2015 - 2016)
Baltimore, MD (US) (2020 - 2023)
Clarksville, MD (US) (2007 - 2024)

Company Filing History:

30 out of 3,798

Johns Hopkins University

patents

4 out of 8,578

Massachusetts Institute of Technology

patents

3 out of 1,327

Texas A&M University System

patents

4. 2 out of 3,346

Chinese Academy of Sciences

patents

5. 1 out of 2

Rapafusyn Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 1999-2026

Loading Chart...

Areas of Expertise:

Angiogenesis Inhibitors

Immunosuppressive Agents

Hybrid Cyclic Libraries

GLUT Inhibitors

Equilibrative Nucleoside Transporter

Cell Death Induction

Protein Microarrays

Triptolide Analogues

Methionine Aminopeptidases

Hedgehog Pathway Antagonists

Anticancer Agents

Itraconazole Analogs

35 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12753200 - Glucose triptolide conjugates and uses thereof (2026-10-06),

2. 12662493 - Non-immunosuppressive FK506 analogs and use thereof (2026-06-23),

3. 12649980 - Three-dimensional surface for protein and small molecule microarrays (2026-06-09),

4. 12565518 - Hybrid cyclic libraries and screens thereof (2026-03-03),

5. 12545666 - Itraconazole analogs and use thereof (2026-02-10),

6. 12049521 - Hybrid cyclic libraries and screens thereof (2024-07-30),

7. 11878045 - Inducing cell death by hyperactivation of motility networks (2024-01-23),

8. 11708391 - Rapaglutins, novel inhibitors of GLUT and use thereof (2023-07-25),

9. 11555054 - Rapadocins, inhibitors of equilibrative nucleoside transporter 1 and uses thereof (2023-01-17),

10. 11458141 - Aryl hydrocarbon receptor (AhR) agonists for the prevention and treatment of inflammatory disorders (2022-10-04),

11. 11066416 - Rapafucin derivative compounds and methods of use thereof (2021-07-20),

12. 11028078 - Itraconazole analogs and use thereof (2021-06-08),

13. 10954273 - Hybrid cyclic libraries and screens thereof (2021-03-23),

14. 10869908 - Inducing cell death by hyperactivation of motility networks (2020-12-22),

15. 10774110 - Rapadocins, inhibitors of equilibrative nucleoside transporter 1 and uses thereof (2020-09-15),

Title: The Innovative Journey of Jun O Liu

Introduction: Jun O Liu is a renowned inventor based in Clarkesville, MD (US) known for his groundbreaking contributions to the field of biotechnology and pharmaceuticals.

Latest Patents: Jun O Liu holds several patents in the areas of drug discovery, molecular biology, and bioinformatics, showcasing his continuous commitment to innovation and research.

Career Highlights: With a distinguished career spanning over two decades, Jun O Liu has held key positions in leading research institutions and biotech companies, where he has spearheaded numerous projects that have led to significant advancements in the medical field.

Collaborations: Throughout his career, Jun O Liu has collaborated with top scientists, researchers, and pharmaceutical companies globally, fostering a culture of innovation and knowledge exchange that has resulted in the development of cutting-edge technologies and life-saving medications.

Conclusion: Jun O Liu's passion for innovation, coupled with his relentless pursuit of scientific excellence, has solidified his reputation as a visionary inventor whose work continues to impact the world of biotechnology and pharmaceuticals.